Talampanel Completed Phase 2 Trials for Brain and Central Nervous System Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00064363Talampanel in Treating Patients With Recurrent High-Grade Glioma